Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Overview, Analysis And Demand By 2034


Get 30% Off All Market Studies With Code ONLINE30 – Anticipate Tariff Impacts, Market Disruptors, and Long-Term Growth Trends

What Is the Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market Growth Potential Across Different Regions?
The artificial intelligence (AI) in in vitro diagnostics (IVD) market size has grown rapidly in recent years. It will grow from $2.57 billion in 2024 to $3.04 billion in 2025 at a compound annual growth rate (CAGR) of 18.5%. The growth in the historic period can be attributed to a growing shortage of skilled healthcare professionals and radiologists, increasing government and regulatory support for artificial intelligence-based diagnostics, rising application of artificial intelligence in genomic and molecular diagnostics, growing awareness about artificial intelligence-enabled diagnostic accuracy among clinicians, and rising availability of cloud-based artificial intelligence diagnostic solutions.

The artificial intelligence (AI) in in vitro diagnostics (IVD) market size is expected to see rapid growth in the next few years. It will grow to $5.94 billion in 2029 at a compound annual growth rate (CAGR) of 18.2%. The growth in the forecast period can be attributed to increasing demand for rapid and accurate diagnostic results, rising prevalence of chronic and infectious diseases, rising need for personalized and precision medicine approaches, growing focus on early disease detection and prevention, and increasing healthcare digitization and electronic health record (EHR) adoption. Major trends in the forecast period include advancement in deep learning for pathology and imaging, innovation in fully automated high-throughput analyzers, integration of natural language processing in diagnostic reporting, advancement in AI-enabled remote diagnostic platforms, and integration of AI with wearable and point-of-care devices.

Claim your free report sample now:
https://www.thebusinessresearchcompany.com/sample.aspx?id=28120&type=smp

What Are the Critical Growth Contributors in the Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?
The increasing demand for personalized medicine is expected to propel the growth of artificial intelligence (AI) in in vitro diagnostics (IVD) market going forward. Personalized medicine refers to a healthcare approach that customizes prevention, diagnosis, and treatment based on an individual’s genetic profile, lifestyle, and environment. Personalized medicine is increasing as advances in genomic data and sequencing technologies enable more accurate, targeted, and effective treatments tailored to individual patients. Artificial intelligence (AI) in in vitro diagnostics (IVD) helps personalized medicine by analyzing complex diagnostic data to identify patient-specific disease patterns, enabling precise, timely, and tailored treatment decisions. For instance, in February 2024, according to the Personalized Medicine Coalition, a US-based non-profit organization, in 2023, the FDA approved 16 new personalized treatments for rare disease patients, up from six in 2022. The newly approved personalized treatments for 2023 also include seven cancer drugs and three for other diseases and conditions. Therefore, the increasing demand for personalized medicine is driving the growth of artificial intelligence (AI) in in vitro diagnostics (IVD) market.

Which Segments Are Attracting Maximum Investment in the Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?
The artificial intelligence (AI) in in vitro diagnostics (IVD) market covered in this report is segmented as

1) By Component: Software, Hardware, Services
2) By Technology: Machine Learning, Natural Language Processing, Computer Vision, Robotics Process Automation, Deep Learning
3) By Deployment Model: Cloud-Based, On-Premise, Hybrid
4) By Application: Diagnostic Imaging, Laboratory Testing, Pathology, Genomics, Personalized Medicine
5) By End User: Hospitals And Clinics, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Medical Device Manufacturers

Subsegments:
1) By Software: Diagnostic Algorithms, Data Analytics Platforms, Decision Support Systems
2) By Hardware: Laboratory Instruments, Imaging Devices, Point-Of-Care Devices
3) By Services: Consulting And Implementation, Maintenance And Support, Training And Education

What Are the Future Trends Forecasted for the Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?
Major companies operating in the artificial intelligence (AI) in in vitro diagnostics (IVD) market are focusing on developing advanced solutions, such as CE-IVDR-certified transparent AI platforms, to enhance diagnostic accuracy, streamline workflows, and support personalized patient care. A CE-IVDR-certified transparent AI platform is an AI system for in vitro diagnostics that meets EU regulatory standards and provides clear, auditable, and understandable decision-making. For instance, in May 2025, Diagnostics.ai, a UK-based diagnostic testing company, launched PCR.AI, a smart solution to accelerate and enhance PCR diagnostics. That automates and accelerates the interpretation of real-time PCR diagnostics with over 99.9% accuracy. It offers transparency by clearly showing how each result is derived, ensuring regulatory compliance and boosting clinical trust. This significantly enhances laboratory efficiency, reduces errors, and supports seamless regulatory adherence for molecular diagnostics.

Which Are the Major Market Players in the Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Industry?
Major companies operating in the artificial intelligence (AI) in in vitro diagnostics (IVD) market are Roche Diagnostics GmbH, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Siemens Healthineers AG, Illumina Inc., Hologic Inc., Sysmex Corporation, QIAGEN N.V., Tempus Labs Inc., BillionToOne Inc., PathAI Inc., Proscia Inc., Indica Labs Inc., Visiopharm A/S, aetherAI Co. Ltd., Ibex Medical Analytics Ltd., Mindpeak GmbH, OncoHost Ltd., Qritive, and Aiforia Technologies Oyj.

Get the full artificial intelligence (ai) in in vitro diagnostics (ivd) market report here:
https://www.thebusinessresearchcompany.com/report/artificial-intelligence-ai-in-in-vitro-diagnostics-ivd-global-market-report

Which Regions Are Forecasted to Experience the Fastest Growth in the Artificial Intelligence (AI) In In Vitro Diagnostics (IVD) Market?
North America was the largest region in the artificial intelligence (AI) in in vitro diagnostics (IVD) market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in artificial intelligence (AI) in in vitro diagnostics (IVD) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Contact Us:

The Business Research Company

https://thebusinessresearchcompany.com/

Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267

Email: info@tbrc.info

Follow Us On:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

Comments

Post a Comment

Popular posts from this blog

Hypertrophic Cardiomyopathy (HCM) Therapeutics Market Scope, Share Analysis And Growth 2025

Image
Focused on real-world business use, this report highlights what’s changing in the hypertrophic cardiomyopathy (hcm) therapeutics market and what companies should prepare for next. What Is The Projected Market Size & Growth Rate Of The Hypertrophic Cardiomyopathy (HCM) Therapeutics Market? The hypertrophic cardiomyopathy (hcm) therapeutics market size has grown marginally in recent years. It will grow from $1.34 billion in 2024 to $1.37 billion in 2025 at a compound annual growth rate (CAGR) of 1.5%. The growth in the historic period can be attributed to diagnostic advancements, increased disease awareness, drug development and approvals, rising healthcare expenditure, government initiatives and funding. The hypertrophic cardiomyopathy (hcm) therapeutics market size is expected to see steady growth in the next few years. It will grow to $1.56 billion in 2029 at a compound annual growth rate (CAGR) of 3.4%. The growth in the forecast period can be attributed to genetic research and ...
Read more

Glycomics or Glycobiology Market Scope, Share Analysis And Growth 2025

Image
Backed by rigorous analysis and deep industry knowledge, this study is designed to support growth and investment decisions in the glycomics or glycobiology market. How Big Is The Glycomics or Glycobiology Market In 2025? The glycomics or glycobiology market size has grown rapidly in recent years. It will grow from $1.85 billion in 2024 to $2.13 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to increased awareness of glycans in biological systems, expansion of glycan-related database and resources, rise in collaborative research initiatives, advancements in glycan synthesis and engineering, glycan biomarker identification. The glycomics or glycobiology market size is expected to see rapid growth in the next few years. It will grow to $3.99 billion in 2029 at a compound annual growth rate (CAGR) of 17.0%. The growth in the forecast period can be attributed to glycan-focused artificial intelligence (AI) and data analy...
Read more

Smart Crop Monitoring Market Overview, Analysis And Demand By 2034

Image
Aimed at strategic decision-makers, this report explores current opportunities, emerging trends, and market dynamics shaping the smart crop monitoring sector. How Big Is The Smart Crop Monitoring Market In 2025? The smart crop monitoring market size has grown rapidly in recent years. It will grow from $3.47 billion in 2024 to $4.09 billion in 2025 at a compound annual growth rate (CAGR) of 18.0%. The growth in the historic period can be attributed to rising demand for high crop production, increasing global population, significant growth in IOT technology, rising need for sustainable agricultural practices, and increasing regulatory pressures. The smart crop monitoring market size is expected to see rapid growth in the next few years. It will grow to $7.83 billion in 2029 at a compound annual growth rate (CAGR) of 17.6%. The growth in the forecast period can be attributed to the development of automated irrigation systems, the growing trend of farm-to-table movements, an increase in ag...
Read more